The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos


Ocular Microbiology and Immunology Group
Back to OMIG Main Page

< Previous | 2025 Agenda and Abstracts | Next >

 

2025 OMIG Abstract

Antimicrobial Efficacy, Ocular Surface Toxicity, and Cytokine Expression with Povidone-Iodine and Chlorhexidine

Anam Ahmed1, Heather Durkee1, Alison Rodriguez Leiva1, Salomon Merikansky1,3, Suraj Paudyal1,
James Lai1, Felipe Echeverri Tribin1, Alexander Alfonso3, Jorge Maestre-Mesa3, Landon Rohowetz2,
Jean-Marie Parel1,2, Harry W Flynn, Jr.1-3, Nicolas A. Yannuzzi2, Darlene Miller2,3


1Ophthalmic Biophysics Center, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida; 2Anne Bates Leach Eye Center, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida; 3Ocular Microbiology Laboratory, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida


Purpose: To compare the antimicrobial efficacy and ocular surface toxicity of povidone-iodine (PI) and chlorhexidine (CHX) against clinical endophthalmitis isolates, and to evaluate the epithelial viability and inflammatory cytokine response following antiseptic exposure in a corneal tissue model.

Methods: A well diffusion assay was used to assess inhibition zones of PI (5%, 10%) and CHX (0.05%, 0.1%) against 20 microbial isolates, including gram-positive and gram-negative bacteria and Candida albicans. Corneal epithelial tissue models, both uninfected and infected with Staphylococcus epidermidis, were treated with antiseptics. Cell viability was measured via MTT assay. Inflammatory cytokines (IL-6, IL-8, IL-1β, TNF-α) were quantified from supernatant at 30 min, 1 hour, and 24 hours using ELISA.

Results: PI at 5% and 10% demonstrated broader antimicrobial inhibition across most isolates compared to CHX, though CHX had greater efficacy against P. aeruginosa. PI at 0.025% showed no inhibition. CHX-treated corneal tissue retained higher viability (greater percent of living cells) in both healthy and infected models (71–100%) compared to PI (9–17%). PI-treated tissue exhibited elevated inflammatory cytokines, particularly IL-8 and IL-6, with a concentration- and time-dependent increase. CHX induced minimal cytokine release; IL-1β and TNF-α were mostly undetectable in CHX-treated samples.

Conclusions: While PI demonstrated broader antimicrobial efficacy in vitro, it was associated with greater epithelial cytotoxicity and a more pronounced proinflammatory cytokine response. In contrast, CHX-treated tissue retained higher cell viability and induced minimal inflammatory signaling. These findings highlight distinct effects of the two agents on the ocular surface, suggesting that considerations for antiseptic choice could include not only microbial inhibition but also epithelial integrity and inflammatory activation.



Disclosure:
N


Support:

This work was financially supported in part by The Macula Foundation.


< Previous | 2025 Agenda and Abstracts | Next >

 


 

 

space